Form 4: ImageneBio Director Buys 16,000 Shares

ImageneBio Director Joseph P. Slattery purchased 16,000 shares of common stock at $5.99 per share, signaling confidence.

Summary

• ImageneBio, Inc. (IMA) Director Joseph P. Slattery reported the acquisition of 16,000 shares of common stock.
• The transaction occurred on December 24, 2025, at a price of $5.99 per share.
• The purchase was made pursuant to a Rule 10b5-1 plan, indicating a pre-arranged transaction.
• Following this transaction, Mr. Slattery directly beneficially owns 16,000 shares of ImageneBio common stock.

Sentiment

Score: 7

Explanation: The director's purchase of shares is generally a positive signal of confidence in the company's prospects. The transaction being part of a 10b5-1 plan indicates a pre-scheduled decision, which is a structured approach to insider trading.

Positives

• ImageneBio Director Joseph P. Slattery purchased 16,000 shares of common stock, signaling confidence in the company's future.
• The transaction was executed pursuant to a Rule 10b5-1 plan, indicating a pre-scheduled purchase and potentially a long-term positive outlook.

Future Outlook

NA

Industry Context

This filing reports an individual insider transaction and does not provide broader industry context or trends.

Related Party Transactions

• Director Joseph P. Slattery, an insider, purchased 16,000 shares of ImageneBio common stock.

Stakeholder Impact

• Shareholders may view the director's purchase as a positive indicator of management's confidence in the company's future performance, potentially influencing investor sentiment.

Key Dates

Recommendation

The purchase of company stock by a director, even if part of a 10b5-1 plan, generally signals confidence in the company's future prospects. This insider buying can be interpreted as a positive indicator for investors, suggesting potential upside.

Keywords

ImageneBio, IMA, Insider Trading, Form 4, Stock Purchase, Director, Joseph P Slattery, 10b5-1 Plan